— Know what they know.
Not Investment Advice
Also trades as: ECX.DE (XETRA) · $vol 0M · EPGNY (OTC) · $vol 0M

EPGNF OTC

Epigenomics AG
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: +72.3% 5Y: -17.0%
$1.12
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 39 · $1.0M mcap · 759244 float · 0.073% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$1M -92.0% ▼
5Y CAGR: -40.7%
Total Liabilities
$12M -41.2% ▼
5Y CAGR: +23.0%
Shareholders Equity
-$11M -40.3% ▼
Cash & Investments
$960K -54.4% ▼
5Y CAGR: -38.6%
Total Debt
$12M -0.9% ▼
5Y CAGR: +66.8%
Net Debt
$11M +10.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$3M$23M$10M$2M$960K
Short-Term Investments$961K$0$0$0$0
Cash & ST Investments$4M$23M$10M$2M$960K
Net Receivables$305K$73K$90K$299K$0
Inventory$122K$176K$61K$0$0
Other Current Assets$262K$236K$394K$82K$46K
Total Current Assets$5M$24M$11M$2M$1M
Property, Plant & Equip.$1M$891K$2M$3K$0
Goodwill & Intangibles$145K$60K$3M$9K$0
Long-Term Investments$0$0$787K$2M$0
Other Non-Current Assets-$1K$0$4M$8M$20K
Total Non-Current Assets$1M$951K$5M$10M$20K
Total Assets$7M$25M$16M$13M$1M
— Liabilities —
Accounts Payable$629K$503K$4M$286K$0
Short-Term Debt$0$0$0$0$0
Deferred Revenue$2M$69K$1M$0$0
Other Current Liabilities-$481K$984K-$293K-$11K$11K
Total Current Liabilities$2M$2M$5M$275K$11K
Long-Term Debt$0$0$0$12M$12M
Other Non-Current Liab.$36K$31K$89K$9M$475K
Total Non-Current Liabilities$496K$400K$606K$21M$12M
Total Liabilities$3M$3M$6M$21M$12M
— Equity —
Common Stock$6M$16M$4M$853K$908K
Retained Earnings-$91M-$93M-$96M-$85M-$103M
Accumulated OCI$1M-$16K$127K$77M$11M
Total Stockholders Equity$4M$22M$10M-$8M-$11M
Total Liabilities & Equity$7M$25M$16M$13M$1M
— Key Metrics —
Total Debt$683K$460K$841K$12M$12M
Net Debt-$3M-$23M-$9M$10M$11M
Total Investments$961K$0$787K$2M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms